Jong Joseph Kim - Chief Executive Officer, Director at Inovio Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
INO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jong Joseph Kim since 9/17/2023

Holdings reported by Jong Joseph Kim for Inovio Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 139K $1.14M $8.16 Mar 11, 2022 Direct Common Stock
Common Stock 1.42M $797K $0.56 Mar 11, 2022 Direct
Common Stock 817K $457K $0.56 Mar 11, 2022 By Family Limited Partnership
Common Stock 33.8K $18.9K $0.56 Mar 11, 2022 By Son: JK1
Common Stock 33.6K $18.8K $0.56 Mar 11, 2022 By Daughter: EK
Common Stock 33.5K $18.8K $0.56 Mar 11, 2022 By Son: JK2
Common Stock 5.98K $3.35K $0.56 Mar 11, 2022 By Spouse
Common Stock Option 628K Feb 26, 2022 Direct Common Stock

Transactions reported by Jong Joseph Kim for Inovio Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.